Rapid detection of BRCA-1 germ-line mutations by protein truncation test in Tunisian families;Depistage rapide des mutations germinales du gene BRCA 1 par le test de la proteine tronquee chez des familles Tunisiennes

Tunisie Medicale

Volumn 80, Issue 9, 2002, Pages 515-518

  Monastiri, Kamel ^c   Ben Ahmed, Slim ^a   Presneau, Nadége ^b   Bignon, Jean Yves ^b   Chouchane, Lotfi ^c  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b CENTRE JEAN PERRIN   (France)

^c NONE

Author keywords

BRCA 1; Breast ovarian cancer family; Hereditary predis position to breast cancer; Protein truncation test

Indexed keywords

BRCA1 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; DIAGNOSTIC VALUE; EXON; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; HUMAN; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ONCOGENE; ONSET AGE; OVARY CANCER; PROTEIN TRUNCATION TEST; RELATIVE; TUNISIA;

ADULT; AGE OF ONSET; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; TUNISIA;

EID: 0036767463     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BEN AHMED S, MONASTIRI K, CHOUCHANE L, et al. Les prédispositions héréditaires aux cancers du sein: profil épidémiologique et anatomo-clinique de 11 familles dans le Centre Tunisien. Tunisie Médicale 1997;75(3):111-16,
2. CLAUS EB, RISCH N, THOMPSON WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am. J. Hum. Genet. 1991:48:232-42.
3. GANGULY A, LEAHY K, MARSHALL AM, DHULIPALA R, GOD-MILOW L, GANGULY T. Genetic testing for breast cancer susceptibility: frequency of BRCA-1 and BRCA-2 mutations. Genet. Test 1997;1(2):85-90.
4. GARVIN AM, ATTENHIFER-HANER M, SCOTT RJ. BRCA 1 and BRCA 2 mutation analysis in 86 early onset breast/ovarian cancer patients. J. Med. Genet. 1997;34:990-95.
5. MIKI Y, SWENSEN J, SHATTUCK-EIDENS D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA 1. Science 1994;266:66-71.
6. BERSTWISTLE D, ASHWORTH A. Fonctions of the BRCA-1 and BRCA-2 genes. Curr. Opin. Genet. Dev. 1998;8:14-20.
7. Breast Cancer Information Core (BIC): http://www.nchgr.nih.gov/Intramural_research/Lab_transfer/BIC
8. GAYTHER SA, WARREN W, MAZOYER S, et al. Germ-line mutations of the BRCA 1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat. Genet. 1995:11:428-33.
9. HOGERVORST FBL, CORNELIS RS, BOUT M, et al. Rapid detection of BRCA-1 mutations by the protein truncation test. Nat. Genet. 1995;10:208-12.
10. PLUMMER SJ, ANTON-CULVER H, WEBSTER L, et al. Detection of BRCA-1 mutations by the protein truncation test. Hum. Mol. Genet. 1995;4:1989-91.
11. SHATTUCK-EIDENS D, Mc CLURE M, SIMARD J, et al. A collaborative survey of 80 mutations in the BRCA-1 breast and ovarian cancer susceptibility gene. J Am Med Assoc. 1995;273:535-41.
12. LANCASTER JM, COCHRAN CJ, BROWNLEE HA, et al. Detection of BRCA-1 mutations in women with early-onset ovarian cancer by use of the protein truncation test. J Natl Cancer Inst. 1996;88:552-54.
13. Groupe "Génétíque et Cancer", Fédération nationale de lutte contre le cancer. Mise en place d'un protocole évalué de dépistage du cancer du sein chez les femmes reconnues à risque génétique. Path. Biol. 1994;42:109-13.
14. SAMBROOK J, FRITSCH EF, MANIATIS T. Molecular Cloning. A laboratory manual. 2nd eds. Cold Spring Harbor Laboratory Press, 1989.
15. LAPLACE-MARIEZE V, PRESNEAU N, SYLVAIN V, et al. Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French breast/ovarian cancer families. Int. J. Oncol. 1999;14(5):971-7.
16. PRESNEAU N, LAPLACE-MARIEZE V, SYLVAIN V, et al. New mechanism of BRCA-1 mutation by deletion/insertion at the same nucleotide position in three unrelated French breast/ovarian cancer families. Hum. Genet. 1998;103(3):334-9.
17. STRUEWING JP, TARONE RE, BRODY LC, et al. BRCA-1 mutations in young women with breast cancer. Lancet 1994;347:1493.
18. EASTON DF, BISHOP DT, FORD D, et al. Consortium genetic linkage analysis in familial breast and ovarian cancers. Results from 214 families. Am. J Hum Genet. 1993;52:678-701.
19. NAROD SA, FORD D and the Breast Cancer Linkage Consortium. An evaluation of genetic heterogeneity in 145 breast/ovarian cancers revisited. Am. J Hum. Genet. 1995:57:957-58.
20. FITZGERALD MG, Mac DONALD DJ, KRAINER M, et al. Germ-line mutations in Jewish and Non-Jewish women early-onset breast cancer. N. Engl. J. Med. 1996;334:143-9.
21. FORD D, EASTON DF, PETO J. Estimates of the gene frequency of BRCA-1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995;57:1457-62.
22. LAAGSTON AA, MALONE KE, THOMPSON JD, OSTRANDER EA. BRCA-1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 1996;334:137-42.
23. De BERNEDETTI VM, RADICE P, MONDINI P, et al. Screening for mutations in exon 11 of the BRCA-1 gene in 70 italian breast and ovarian cancer patients by protein truncation test. Oncogene 1996;13(6):1353-7.
24. MOORE W, BOGDARIANE I, PATEL VA, et al. Mutation detection in the breast cancer gene BRCA-1 using the protein truncation test. Mol. Biotechnol. 2000;14(2):89-97.
25. PAPELARD H, de BOCK GH, van EIJK R, et al. Prevalence of BRCA-1 in a hospital-based population of Dutch breast cancer patients. Br J Cancer 2000;83(6):719-24.
26. SHATTUCK-EIDENS D, OLIPHANT A, Mc CLURE M, Mc BRIDE C, et al. BRCA-1 sequence analysis in women at high risk for susceptibility mutations. JAMA 1997;278:1242-50.